K. Kalantar-Zadeh, J. D. Kopple, N. Kamranpour, A. M. Fogelman, M

Slides:

Advertisements

Similar presentations

Kamyar Kalantar-Zadeh Kidney International

Advertisements

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Beta blockers in the management of chronic kidney disease

Volume 70, Issue 3, Pages (August 2006)

Iron indices: What do they really mean?

Volume 69, Issue 11, Pages (June 2006)

Linear and logistic regression analysis

Spectrum and Burden of Erythropoiesis-Stimulating Agent Hyporesponsiveness Among Contemporary Hemodialysis Patients Jiacong Luo, MD, MS, MPH, Donna E.

Impact of Poverty on Serum Phosphate Concentrations in the Third National Health and Nutrition Examination Survey Orlando M. Gutiérrez, MD, MMSc, Tamara.

Surviving the First Year of Peritoneal Dialysis: Enduring Hard Times

C-reactive protein and dialysis access

Association of Relatively Low Serum Parathyroid Hormone With Malnutrition- Inflammation Complex and Survival in Maintenance Hemodialysis Patients Ramanath.

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients G.A. Block, P. Raggi, A. Bellasi, L. Kooienga,

Volume 64, Pages S3-S12 (December 2003)

C-reactive protein and dialysis access

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population Mark J. Sarnak, Bertrand L. Jaber Kidney International

Volume 54, Issue 2, Pages (August 1998)

Volume 88, Issue 2, Pages (August 2015)

Joel D. Kopple, Xiaofei Zhu, Nancy L. Lew, Edmund G. Lowrie

Glycemic Status and Mortality in Chronic Kidney Disease According to Transition Versus Nontransition to Dialysis Connie M. Rhee, MD, MSc, Csaba P. Kovesdy,

Kamyar Kalantar-Zadeh Kidney International

Volume 68, Issue 6, Pages (December 2005)

French peritoneal dialysis registry (RDPLF): Outline and main results

Volume 73, Issue 5, Pages (March 2008)

Survival advantage in Asian American end-stage renal disease patients1

Volume 77, Issue 7, Pages (April 2010)

D. Coyne Kidney International Volume 69, Pages S1-S3 (May 2006)

Volume 77, Issue 2, Pages (January 2010)

Volume 88, Issue 5, Pages (November 2015)

Volume 80, Issue 2, Pages (July 2011)

Christian S. Shinaberger, MPH, Ryan D. Kilpatrick, MS, Deborah L

Volume 92, Issue 2, Pages (August 2017)

Body size and outcomes on peritoneal dialysis in the United States

Blood pressure targets in hemodialysis patients

Volume 69, Issue 10, Pages (May 2006)

Volume 73, Issue 9, Pages (May 2008)

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Volume 70, Issue 10, Pages (November 2006)

Abdulla K. Salahudeen, Erwin H. Fleischmann, John D. Bower

Microbiology and outcomes of peritonitis in North America

Trends and Outcomes Associated With Serum Albumin Concentration Among Incident Dialysis Patients in the United States George A. Kaysen, MD, PhD, Kirsten.

Cardiovascular disease in pediatric chronic dialysis patients

Volume 71, Issue 6, Pages (March 2007)

Alfonso M. Cueto-Manzano, Ricardo Correa-Rotter Kidney International

Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease C.P. Kovesdy, S. Ahmadzadeh,

Volume 79, Issue 2, Pages (January 2011)

Higher serum C-reactive protein predicts short and long-term outcomes in peritoneal dialysis-associated peritonitis N.-Y. Zalunardo, C.-L. Rose, I.W.Y.

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients B. Bammens, P. Evenepoel, H. Keuleers,

Dialysis dose and gender: A different hypothesis

Volume 74, Issue 8, Pages (October 2008)

Racial differences in survival of patients on dialysis

Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants C.A. Solid,

Organ transplantation goes to the movies

Volume 70, Pages S84-S90 (November 2006)

Volume 70, Issue 8, Pages (October 2006)

Charles A. Herzog Kidney International

Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley

Volume 74, Issue 6, Pages (September 2008)

Volume 70, Issue 3, Pages (August 2006)

Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes Steven M. Brunelli, Ravi Thadhani,

Volume 61, Issue 2, Pages (February 2002)

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Associations of hemodialysis dose and session length with mortality risk in Australian and New Zealand patients M.R. Marshall, B.G. Byrne, P.G. Kerr,

Mary B. Leonard, Lynn A. Donaldson, Martin Ho, Denis F. Geary

E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins

Estimated daily P intake (in mg/d) from daily protein intake (in g/d) in 107 MHD patients from the NIED Study (30). Estimated daily P intake (in mg/d)

Stephen Pastan, J. Michael Soucie, William M. McClellan

Among three residual kidney function (RKF) indices, only residual urine volume (UV) indicated an independent prognostic value in patients with UV≥0.1 or.

Presentation transcript:

HDL-inflammatory index correlates with poor outcome in hemodialysis patients K. Kalantar-Zadeh, J.D. Kopple, N. Kamranpour, A.M. Fogelman, M. Navab Kidney International Volume 72, Issue 9, Pages 1149-1156 (November 2007) DOI: 10.1038/sj.ki.5002491 Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 1 Distribution of the measured ‘HDL-inflammatory index’ (HII) in 189 MHD patients. Kidney International 2007 72, 1149-1156DOI: (10.1038/sj.ki.5002491) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 2 Odds ratio of HII≥1 in 189 MHD patients among the a priori selected categories of total body fat percentage based on fat percentage increments of 10%. Case-mix models are adjusted for age, gender, race and ethnicity, diabetes, Charlson comorbidity scale, and dialysis vintage. Case-mix and MICS-adjusted models are also controlled for serum albumin, CRP, and IL-6. Kidney International 2007 72, 1149-1156DOI: (10.1038/sj.ki.5002491) Copyright © 2007 International Society of Nephrology Terms and Conditions

Figure 3 Kaplan–Meier proportion of surviving MHD patients after 30 months of observation using an HII cutoff level of 1 in the cohort of 189 MHD patients of the NIED Study. Upper panel: unadjusted survival. Lower panel: adjusted for case-mix variables, including age, race and ethnicity (Blacks, Asians, and Hispanics), diabetes mellitus, Charlson comorbidity score, dialysis vintage, dialysis dose (Kt/V), and body fat percentage according to the NIR measurements. Kidney International 2007 72, 1149-1156DOI: (10.1038/sj.ki.5002491) Copyright © 2007 International Society of Nephrology Terms and Conditions